Global Esthetic
- Address
- 56 Avenue Victor Hugo, 75116 Paris, France
Global Esthetic - Aesthetic Medicine Research Center
Global Esthetic is a specialized research facility focused on advancing aesthetic medicine through clinical investigation of innovative cosmetic treatments. The center demonstrates expertise in evaluating non-surgical interventions for facial contouring and aesthetic enhancement procedures.
- Botulinum toxin applications for facial aesthetics and muscle modification
- Treatment of masseter muscle prominence and facial slimming procedures
- Safety and efficacy assessment of cosmetic injectable therapies
The research center conducts rigorous placebo-controlled studies to evaluate BOTOX (Botulinum Toxin Type A) for cosmetic indications, with particular emphasis on masseter muscle prominence reduction. Their clinical trials aim to establish evidence-based protocols for facial aesthetic procedures, contributing to the growing body of knowledge in minimally invasive cosmetic medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Global Esthetic
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| BOTOX® (Botulinum toxin type A) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Oct 2023 | Oct 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Botulinum Toxin Type A | 1 | Unknown | 2023-10-11 | 2023-10-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.